Literature DB >> 4614326

Present experiences with hepatic dearterialization in liver neoplasm.

S Bengmark, P Fredlund, L O Hafström, J Vang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4614326     DOI： 10.1159/000395682

Source DB:  PubMed          Journal:  Prog Surg        ISSN： 0079-6824


× No keyword cloud information.
  10 in total

1.  Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.

Authors:  E C Lai; T K Choi; S W Tong; G B Ong; J Wong
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 2.  Controlling the carcinoid syndrome.

Authors:  H J Hodgson
Journal:  BMJ       Date:  1988-11-12

3.  Temporary liver dearterialization in patients with metastatic carcinoid disease.

Authors:  S Bengmark; M Ericsson; A Lunderquist; H Mårtensson; A Nobin; M Sako
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

4.  Primary carcinoma of the liver: improvement in sight?

Authors:  S Bengmark; L Hafström; B Jeppsson; K Sundqvist
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

5.  Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors.

Authors:  E P Dahl; P E Frelund; U Tylén; S Bengmark
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

6.  Isolated liver perfusion using percutaneous methods: an experimental study in the pig.

Authors:  J Harnek; W Cwikiel; L Bergqvist; B Persson; H Stridbeck
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

7.  Effect on liver tumor growth in rats of allopurinol and 5-fluorouracil in combination with hepatic artery ligation.

Authors:  G Carlsson; B Gustavsson; L Hafström
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  Repeated hepatic ischemia as a treatment for carcinoid liver metastases.

Authors:  B G Persson; A Nobin; B Ahrén; B Jeppsson; B Månsson; S Bengmark
Journal:  World J Surg       Date:  1989 May-Jun       Impact factor: 3.352

Review 9.  Neuroendocrine metastases of the liver.

Authors:  I Ihse; B Persson; S Tibblin
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

10.  Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours.

Authors:  F Marrache; M P Vullierme; C Roy; Y El Assoued; A Couvelard; D O'Toole; E Mitry; O Hentic; P Hammel; P Lévy; P Ravaud; P Rougier; P Ruszniewski
Journal:  Br J Cancer       Date:  2006-12-12       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.